Trial of Prophylactic Versus Empirical Vancomycin for the Prevention of Streptococcal Sepsis After Hematopoietic Cell Transplantation
PHASE3CompletedINTERVENTIONAL
Enrollment
126
Participants
Timeline
Start Date
November 30, 2003
Study Completion Date
November 30, 2005
Conditions
Streptococcal SepsisHematologic Malignancies
Interventions
DRUG
Empirical Vancomycin
DRUG
Prophylactic Vancomycin
Trial Locations (1)
10021
Memorial Sloan-Kettering Cancer Center, New York
All Listed Sponsors
lead
Memorial Sloan Kettering Cancer Center
OTHER
NCT00138112 - Trial of Prophylactic Versus Empirical Vancomycin for the Prevention of Streptococcal Sepsis After Hematopoietic Cell Transplantation | Biotech Hunter | Biotech Hunter